Van Hulzen Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Van Hulzen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$543.48 - $670.97 $195,652 - $241,549	-360 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $57,403 - $68,096	-100 Reduced 21.74%	360 $218,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $28,698 - $36,478	-60 Reduced 11.54%	460 $222,000
Q3 2020 Nov 03, 2020	BUY	$544.75 - $658.21 $76,265 - $92,149	140 Added 36.84%	520 $291,000
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $187,461 - $244,689	380 New	380 $237,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.